Bruno Permanne, PhD
Head of Biology at Asceneuron S.A.
Location: Lausanne, Switzerland
Bruno Permanne, PhD, is the head of biology at Asceneuron. Dr. Permanne obtained his PhD in biochemistry at the University of Lille under the co-supervision of Dr. Andre Delacourte and Dr. Luc Buée. He completed postdoctoral training in the laboratory of Professor Blas Frangione at the NYU Medical Center in New York, New York; both groups are recognized for their work on the pathophysiology of the tau protein and amyloidogenesis in neurodegenerative diseases.
Dr. Permanne has more than 15 years of experience in drug discovery programs on neurodegenerative diseases (Alzheimer’s disease, Parkinson’s disease and tauopathies). Previously, he was a project team leader at Merck Serono in Switzerland, where he successfully ran drug discovery programs resulting in the progression of small molecules from high-throughput screens to the lead optimization stage. At Asceneuron, Dr. Permanne is responsible for assay development, pharmacology activities and biomarker development with a focus on neurodegeneration and cognitive improvement. He is author of 13 peer-reviewed publications.